Frost & Sullivan's recent analysis, Global Pharmaceuticals Outlook, finds that the accelerated drug development timelines are driving digitalization and innovation across the pharmaceutical value...
Nordic Bioscience, a growing biomarker company, announced the strengthening of its ongoing collaboration with Roche Diagnostics for the development of proprietary biomarkers involved in...
Sirnaomics Ltd., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced the peer-reviewed publication of Phase IIa clinical study results of...
